NCT05014477|Unknown
Therapy Strategies After LAA Occluder Device Embolization
LAAODE
Device Embolization After Percutaneous Left Atrial Appendage Occlusion: Risk Factors, Approaches and Outcomes
Loading search results
LAAODE
Device Embolization After Percutaneous Left Atrial Appendage Occlusion: Risk Factors, Approaches and Outcomes
Sponsor study identifier
observational
400
1 country
1
Study Start
September 30, 2020
Actual (reported)Primary Completion
September 30, 2021
Actual (reported)Study Completion
December 31, 2023
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
The investigators thought to evaluate risk factors, therapeutic approaches and outcomes after left atrial appendage occluder device embolization (LAAO, either surgical or interventional).
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
December 31, 2023
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
September 30, 2020
Actual (reported)August 12, 2021
Actual (reported)August 20, 2021
Actual (reported)September 30, 2021
Actual (reported)December 31, 2023
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Procedural mortality
all-cause mortality during the index procedure, any procedure-related death within 30days or during in-hospital stay for the index procedure (if\>30days)
In-hospital stay, assessed up to 30 days
Need for cardiac surgery
In-hospital stay, assessed up to 30 days
Catheter-based retrieval of LAA Occluder
peri-procedural device removal
up to 5 years (after device implantation)
Device embolization following either surgical or interventional left atrial appendage occlusion
After LAA device embolization there are different approaches to dealing with the occluder dislocation. The aim is to find out which way leads to the best outcomes.
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
Patients after interventional or surgical left atrial appendage occlusion with device embolization
CardioVascular Center (CVC) Frankfurt
Frankfurt on the Main, Hesse, 60389, Germany
Eppinger S, Piayda K, Galea R, Sandri M, Maarse M, Guner A, Karabay CY, Pershad A, Ding WY, Aminian A, Akin I, Davtyan KV, Chugunov IA, Marijon E, Rosseel L, Schmidt TR, Amabile N, Korsholm K, Lund J, Guerios E, Amat-Santos IJ, Boccuzzi G, Ellis CR, Sabbag A, Ebelt H, Clapp B, Assa HV, Levi A, Ledwoch J, Lehmann S, Lee OH, Mark G, Schell W, Della Rocca DG, Natale A, de Backer O, Kefer J, Esteban PP, Abelson M, Ram P, Moceri P, Galache Osuna JG, Alvarez XM, Cruz-Gonzalez I, de Potter T, Ghassan M, Osadchiy A, Chen W, Goyal SK, Giannini F, Rivero-Ayerza M, Afzal S, Jung C, Skurk C, Langel M, Spence M, Merkulov E, Lempereur M, Shin SY, Mesnier J, McKinney HL, Schuler BT, Armero S, Gheorghe L, Ancona MBM, Santos L, Mansourati J, Nombela-Franco L, Nappi F, Kuhne M, Gaspardone A, van der Pals J, Montorfano M, Fernandez-Armenta J, Harvey JE, Rodes-Cabau J, Klein N, Sabir SA, Kim JS, Cook S, Kornowski R, Saraste A, Nielsen-Kudsk JE, Gupta D, Boersma L, Raber L, Sievert K, Sievert H, Bertog S. Embolization of percutaneous left atrial appendage closure devices: Timing, management and clinical outcomes. Cardiovasc Revasc Med. 2024 Jul;64:7-14. doi: 10.1016/j.carrev.2024.02.014. Epub 2024 Feb 28.
Sophie Eppinger
CardioVascular Center (CVC) Frankfurt, Seckbacher Landstraße 65, 60389 Frankfurt am Main, Hesse, Germany
First Submitted
August 12, 2021
First Posted
August 20, 2021
Study Start
September 30, 2020
Actual (reported)Primary Completion
September 30, 2021
Actual (reported)Risk Factors in Young Middle Eastern Women With Cardiovascular Disease
Risk Factors for Severe Periodontitis in 30 to 40 Year Olds: a Retrospective Study
Further complications
up to 5 years (after device implantation)
Risk factors
up to 30 days (after device implantation)
Contact the study team to confirm eligibility.
Study Completion
December 31, 2023
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Last Updated
July 26, 2022
Record last verified: 2022-07
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: